Phelophepa Train offers 2-week trip to Africa as prize in donation drive

Article

The American Friends of the Phelophepa Train are launching their first first-ever Eye Clinic Donation Drive to raise funds for the purchase of 50,000 pairs of eyeglasses to be dispensed at the eye clinic on board 18-car trains that travel throughout South Africa delivering primary healthcare services to under-served villagers.

 

New York-The American Friends of the Phelophepa Train (AFPT) are launching their first first-ever Eye Clinic Donation Drive to raise funds for the purchase of 50,000 pairs of eyeglasses to be dispensed at the eye clinic on board 18-car trains that travel throughout South Africa delivering primary healthcare services to under-served villagers.

The Donation Drive offers the opportunity to win a 14-day trip to South Africa for two people valued at $40,000, including a day on-board the Phelophepa Train. For every $5 donation, donors will be entered into a sweepstakes drawing to win this luxury trip.

The objective of this fundraising drive is to raise awareness that nearly two thirds of all blindness in rural Africa is avoidable through early detection, prevention, and management programs to reduce the impact of visual impairment. The goal of this campaign is to fund the purchase of 50,000 pairs of eyeglasses that the train dispenses each year and to raise money to support the cataract, refractive, and glaucoma treatment programs provided by Phelophepa.

The Phelophepa Train has served more than 14.5 million people and distributed more than 500,000 pairs of eyeglasses since it began operating in 1994. In a country where 80% of people have inadequate access to eyecare services and where more than 100 people go blind every day due to preventable causes, Phelophepa has become known as the Train of Hope.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.